 |
인쇄하기
취소
|
Dong-A PharmTech announces start of Phase II trials for Udenafil in Mexico
Dong-A PharmTech Co. announced Monday that it will carry out Phase II clinical trials for Zydena (udenafil), a new long acting drug for treatment of erectile dysfunction (ED), in Mexico.
In its regulatory filing, the company said that the Phase II study is designed to evaluate the safety and efficacy of Zydena 25 mg, 50 mg, 75 mg in patients with benign prostatic hyperplasia (BPH) over 12 we...
In its regulatory filing, the company said that the Phase II study is designed to evaluate the safety and efficacy of Zydena 25 mg, 50 mg, 75 mg in patients with benign prostatic hyperplasia (BPH) over 12 we...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.